HAS Corporate Logo HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources
Contact Us
  • Sun images
  • Vector Images
HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources

Gastroparesis Awareness Month

Related services

Let's talk

  • Richard Tuson
  • /
  • 1 Aug 2025

August is Gastroparesis Awareness Month 

Understanding the Condition Gastroparesis, meaning “stomach paralysis”, occurs when nerve damage — often from diabetes, surgery, certain medications, or illness — slows the stomach’s ability to empty food. This delay is not caused by a blockage or structural abnormality. The impact on patients can be significant, with symptoms such as nausea, vomiting, early satiety, and abdominal pain.

For innovators, such as Enterra Medical, Inc. this is an area of continued unmet need. Advances in diagnostic tools and novel device-based therapies, such as gastric electrical stimulation and emerging non-invasive approaches, are creating new opportunities for earlier intervention and improved quality of life.

As well as this, Guts UK Charity is tackling this head-on by funding research, raising awareness, and empowering patient voices. Their work is bringing hope — and change — to a community that has been overlooked for too long.

At Health Analytical Solutions Ltd, with over 20 years of expertise in NHS coding, reimbursement, and adoption pathways, we support companies in mapping UK access routes, aligning clinical evidence with NICE expectations, and navigating commissioning frameworks to bring innovations in this field to patients sooner.

 

Our Latest Insights.

 
  • Richard Tuson

June 2025 NHS Diagnostic Waiting Lists

 
  • Richard Tuson

Community Diagnostic Centres: Extending Access and Reducing Delays

 
  • Richard Tuson

Where the Pressure Sits

 
  • Richard Tuson

Waiting List Rises Again

Health Analytical Solutions

  • About
  • Services
  • Blog
  • Resources
  • Contact Us

Services

  • Market Access Analytics and Insight
  • NICE HTA Strategy and Submission
  • Health Economics and Outcomes Research (HEOR)
  • Strategy Development
  • Reimbursement Strategy and Support
  • NHS Drug Tariff Submission Support
  • Private healthcare
  • Value Proposition Development for MedTech
  • Primary Care Market Insights
  • Stakeholder Engagement for Health Technologies
  • Sustainability and NET Zero for MedTech
  • Evidence Generation and Management
  • Dashboard Tools for Market Access
  • MedTech Sales Team Empowerment
  • NHS MedTech Business Case Formulation

Stay Up To Date

  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Contact Us

© Health Analytical Solutions 2025